Arcturus Therapeutics Holdings Inc.
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
ARCT | US
Overview
Corporate Details
- ISIN(s):
- US03969T1097
- LEI:
- Country:
- United States of America
- Address:
- 10628 SCIENCE CENTER DRIVE, 92121 SAN DIEGO
- Website:
- https://arcturusrx.com/
- Sector:
- Manufacturing
Description
Arcturus Therapeutics Holdings Inc. is a commercial-stage messenger RNA (mRNA) medicines company focused on the discovery, development, and commercialization of therapeutics and vaccines. The company's primary areas of interest are infectious diseases and rare diseases, with a particular emphasis on respiratory and liver conditions. Its development pipeline includes candidates for Ornithine Transcarbamylase (OTC) deficiency (ARCT-810) and Cystic Fibrosis (ARCT-032), as well as vaccine programs. Arcturus leverages its proprietary technologies, including the LUNAR® lipid-mediated nanoparticle delivery system and the STARR® self-amplifying mRNA platform, to advance its portfolio of RNA-based medicines.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Arcturus Therapeutics Holdings Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Arcturus Therapeutics Holdings Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Arcturus Therapeutics Holdings Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
